Arnall Justin R, Moore Donald C, Michael Meghan, Wolcott Michael, Cowgill Nicole
Specialty Pharmacy Servivce, Atrium Health, Charlotte, NC, USA.
Levine Cancer Institute, Atrium Health, Concord, NC, USA.
Hosp Pharm. 2023 Jun;58(3):282-288. doi: 10.1177/00185787221137901. Epub 2022 Dec 1.
Patients with bleeding disorders are best served by multidisciplinary teams. Pharmacists can play a critical role in the optimal management of patients with bleeding disorders through blood factor stewardship strategies and programs. An educational program was developed and implemented wherein a hematology pharmacist provided brief recorded lectures to an entire department of pharmacists in a multi-site health-system with the goal to improve the knowledge base and confidence among this population of general practitioners. The primary objective of this study was to evaluate the educational outcomes of a blood factor education program for pharmacists. The impact of the educational program was determined by measuring the difference in mean test scores between the pre- and post-program surveys. The final analysis included 214 participants. The primary endpoint of mean competency test score was significantly improved in the post-test compared to pre-test (78.33% vs 52.83%; < .0001). Any degree of test score improvement was observed in 99% ( = 212) of participants. Pharmacist confidence was significantly improved in all 20 domains of bleeding disorders and blood factor product verification and management. This program identified that most pharmacists in a large multi-site health-system were not familiar with bleeding disorders to a satisfactory degree, commonly because of the relative rare encounters with bleeding disorder-related orders, and that despite systems-based support there was an opportunity to improve practice through education. Such educational programming could be beneficial for the development of pharmacist-provided care and is a measure that could be implemented as part of blood factor stewardship initiatives.
出血性疾病患者最好由多学科团队来服务。药剂师可以通过血液因子管理策略和项目,在出血性疾病患者的优化管理中发挥关键作用。开发并实施了一个教育项目,其中一名血液学药剂师为一个多地点医疗系统中整个药剂师部门提供简短的录制讲座,目的是提高这群全科医生的知识基础和信心。本研究的主要目的是评估针对药剂师的血液因子教育项目的教育成果。通过测量项目前和项目后调查的平均测试分数差异来确定教育项目的影响。最终分析包括214名参与者。与测试前相比,测试后的平均能力测试分数这一主要终点有显著提高(78.33%对52.83%;<0.0001)。99%(=212)的参与者观察到测试分数有任何程度的提高。在出血性疾病以及血液因子产品核查和管理的所有20个领域,药剂师的信心都有显著提高。该项目发现,在一个大型多地点医疗系统中,大多数药剂师对出血性疾病的熟悉程度未达到令人满意的水平,通常是因为与出血性疾病相关医嘱的相对罕见,而且尽管有基于系统的支持,但仍有机会通过教育来改进实践。这样的教育项目可能有利于药剂师提供的护理的发展,并且是一项可以作为血液因子管理举措的一部分来实施的措施。